Diabetes drug may be effective against deadly form of breast cancer, study suggests

http://ift.tt/2nbqxu2 Researchers have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer. The study, ‘AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program,’ suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s